Clinical Trials/IRCT20120215009014N431

IRCT20120215009014N431

Not yet recruiting

Phase 3

Evaluation of the response and adverse effects of total neoadjuvant therapy (TNT) of advanced localized rectal cancer: a before-after clinical trial without control group

Hamedan University of Medical Sciences0 sites25 target enrollmentTBD

ConditionsC18.7 Rectal cancer.Malignant neoplasm of sigmoid colon

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: C18.7
Sponsor: Hamedan University of Medical Sciences
Enrollment: 25
Status: Not yet recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Hamedan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

•Age 18 to 75 years
•Advanced localized rectal cancer
•Normal liver, kidney and bone marrow condition

Exclusion Criteria

•Previous chemotherapy
•Former pelvic radiotherapy
•Existence of distant metastasis

Outcomes

Primary Outcomes

Not specified

Similar Trials

The evaluation of subsicion in the correction of nasolabial fold depthasolabial fold.Other atrophic disorders of skin

IRCT201705278146N19Vice chancellor for research,Shahid Beheshti University of Medical Sciences10

Study of the effectiveness of the response and interferon combination therapy for ribavirin monotherapy for chronic hepatitis CChronic hepatitis C

JPRN-UMIN000017560Hokkaido University30

A study on the efficacy of the loss of response to jaw thrust as a clinical test to assess adequate depth of anesthesia using remimazolam besylate and the dose required for the loss of response.

JPRN-jRCT1031210554Okuda Yasuhisa70

Active, not recruiting

Study about the response to the administration of a third dose of mRNA-1273 vaccine (COVID19 vaccine Moderna) in renal transplants with immunological failure initial to vaccinatioCOVID19 vaccine in kidney transplant patientsMedDRA version: 23.1Level: LLTClassification code 10084464Term: COVID-19 immunizationSystem Organ Class: 100000004865MedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 100000004865Therapeutic area: Diseases [C] - Virus Diseases [C02]

EUCTR2021-002356-37-ESFundació Clinic per a la Recerca Biomèdica (FCRB)80

Tamakasvasa management through ayurveda formulation with and without vamanakarma.

CTRI/2019/12/022295J S AYUREVEDA MAHAVIDYALAYA18